Literature DB >> 19970972

Granuloma, a Characteristic "Qualitative" Change in Focal Anaphylactic Inflammation.

J W Goddard.   

Abstract

Entities:  

Keywords:  ANAPHYLACTIC/inflammation and granuloma; GRANULOMA/anaphylactic; INFLAMMATION/anaphylactic and granuloma

Mesh:

Year:  1947        PMID: 19970972      PMCID: PMC1934333     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  10 in total

1.  Hypersensitivity granulomata and the alimentary tract.

Authors:  G SLANEY
Journal:  Ann R Coll Surg Engl       Date:  1962-10       Impact factor: 1.891

2.  Wegener's granulomatosis.

Authors:  E W WALTON; P O LEGGAT
Journal:  J Clin Pathol       Date:  1956-02       Impact factor: 3.411

3.  Granuloma of the nose and periarteritis nodosa.

Authors:  H J M STRATTON; T M L PRICE; M O SKELTON
Journal:  Br Med J       Date:  1953-01-17

4.  Thrombo-embolic primary pulmonary arteriosclerosis.

Authors:  P J BARNARD
Journal:  Br Heart J       Date:  1954-01

5.  Alimentary Granulomata and the Immune Response.

Authors:  G Slaney
Journal:  Postgrad Med J       Date:  1961-05       Impact factor: 2.401

Review 6.  Weber-Christian panniculitis and auto-immune disease: a case report.

Authors:  T G Allen-Mersh
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

7.  [The solitary and multifocal polymorphic granuloma in the nervous system].

Authors:  O Vuia
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1966

8.  Association of retroperitoneal fibrosis, proctitis and rectal stenosis.

Authors:  R Manna; E Caturelli; M G Pigini; M C Lanza-Tomasi; M A Pala; E Zupi
Journal:  Postgrad Med J       Date:  1981-10       Impact factor: 2.401

9.  Neuroreticuloses.

Authors:  S Drăgănescu; O Vula
Journal:  Acta Neuropathol       Date:  1965-07-01       Impact factor: 17.088

10.  Experimental serum disease; a pathogenetic study.

Authors:  W E EHRICH; J SEIFTER; C FORMAN
Journal:  J Exp Med       Date:  1949-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.